- Country: USA
- Summary: Service Agreement on Genetic Analyzer Instrument
- UST Ref No: 118549400
- Deadline: 14 May 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: CBER-2025-128782
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Description
MARKET RESEARCH PURPOSES ONLY
NOT A REQUEST FOR PROPOSAL OR SOLICITATION
The U.S. Food and Drug Administration (FDA) is conducting market research to support the Center for Biologics Evaluation and Research (CBER) requirement for a preventative maintenance, corrective/remedial maintenance repair service agreement on a 3730xL genetic analyzer (a capillary DNA sequencer) and accessories for data acquisition and analysis. DNA Analyzer assigned Serial Number: 33295-004.
The FDA is seeking small business sources to determine the availability and capability of small businesses capable of providing the required services. Other than small business concerns are also encouraged to submit capability statements. The following information is provided to assist the FDA in conducting Market Research to identify potential contractors for this effort.
The associated North American Industry Classification System (NAICS) Code is- 811210 - Electronic and Precision Equipment Repair and Maintenance; the applicable Small Business Size Standard is $34 million.
Statement of Work
I. Statement of Need:
The 3730xL genetic analyzer is an instrument that performs capillary DNA sequencing. Scientists use genetic analyzers to determine sequences of DNA fragments of research interests such as: 1) confirming the authenticity of a DNA fragment amplified by polymerase chain reaction, (PCR); 2) verifying mutations introduced by mutagenesis; 3) validating the orientation of an inserted DNA fragment in an expression vector; 4) revealing sequences of isolated DNA fragments, etc. CBER scientists at FDA conduct research as well as perform regulatory functions. To meet the higher-volume sequencing demands of FDA scientists, FBR uses a high-capacity Applied Biosystems- 3730xL sequencer and associated software programs for data acquisition and analysis. To maintain uninterrupted services to FDA scientists, this requisition is to purchase service contract for the 373... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINService Agreement on Genetic Analyzer Instrument - USA Tender
The HEALTH AND HUMAN SERVICES, DEPARTMENT OF | FOOD AND DRUG ADMINISTRATION, a Government sector organization in USA, has announced a new tender for Service Agreement on Genetic Analyzer Instrument. This tender is published on USARFP under UST Ref No: 118549400 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-05-14.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
